To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

May 1, 2026

Conditions
AKI - Acute Kidney InjuryPneumonia
Interventions
DEVICE

oXiris filter

"Continuous Renal Replacement Therapy with the adsorption membrane filter Oxiris.~The specific septic biomarkers such as interleukin 6(IL-6), procalcitonin (PCT), C-reactive protein (CRP) along with other routine blood investigation results taken at the beginning of therapy and 24 hours after the treatment will be compared."

DEVICE

M100 filter

Continuous Renal Replacement Therapy with the adsorption membrane filter M100. The specific septic biomarkers such as interleukin 6(IL-6), procalcitonin (PCT), C-reactive protein (CRP) along with other routine blood investigation results taken at the beginning of therapy and 24 hours after the treatment will be compared.

Trial Locations (1)

16150

RECRUITING

Hospital Universiti Sains Malaysia (HUSM), Kubang Kerian

All Listed Sponsors
lead

Mohd Zulfakar Mazlan, MBBS

OTHER